NX Prenatal Inc.

LOUISVILLE, KY · Founded 2013 · CIK 0001721472 · Medtech · Private

Non-invasive prenatal blood tests for maternal and fetal health assessment

nxprenatal.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.8M
4 Form D · Aug 2023
38 months since last filing
Contracts
—
No federal contracts on record
Patents
18
3 granted · 15 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$427,536
Private capital raisedForm D · SEC$2,135,583
Private capital raisedForm D · SEC$72,000
Private capital raisedForm D · SEC$3,125,071
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1122Oralucent, Inc.—$2.3M
1123TEAL HEALTH INC—$45M
1124SENOGUARD, INC.——
1125NX Prenatal Inc.—$5.8M
1126iNanoBio, Inc.—$3.3M
1127ZeoVation, Inc.—$780K
1128NOTA Laboratories, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 12 related persons
  • David AdairDirector
  • DAVID ADAIRDirector
  • KEVIN BRAMERDirector
  • Brian BrohmanDirector · Executive Officer
  • BRIAN BROHMANDirector · Executive Officer
  • Mary Lake PolanDirector
  • Alan MackDirector
  • ALAN MACKDirector
  • Gail PageDirector · Executive Officer
  • GAIL PAGEDirector · Executive Officer
  • Robert SaundersDirector
  • ROBERT SAUNDERSDirector

Patents

USPTO · 3 granted of 18
  • Detection Of Microparticle-associated Proteins Associated With Spontaneous Preterm Birthapplication
  • Detection Of Microparticle-associated Proteins Associated With Spontaneous Preterm Birthgranted
  • Use Of Circulating Microparticles To Stratify Risk Of Spontaneous Preterm Birthapplication
  • Tandem-paired Column Chemistry For High-throughput Proteomic Exosome Analysisapplication
  • Systems And Methods Of Using Machine Learning Analysis To Stratify Risk Of Spontaneous Preterm Birthapplication
  • Treatment Of Spontaneous Preterm Birthgranted
  • Treatment Of Spontaneous Preterm Birthgranted
  • Biomarkers Of Preterm Birthapplication
  • Tandem-paired Column Chemistry For High-throughput Proteomic Exosome Analysisapplication
  • Use Of Circulating Microparticles To Stratify Risk Of Spontaneous Preterm Birthapplication
  • Use Of Circulating Microparticles To Stratify Risk Of Spontaneous Preterm Birthapplication
  • Tandem-Paired Column Chemistry for High Throughput Proteomic Exosome Analysisapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.